Form 29C

Form 29C (Tofes 29 Gimel) is a regulatory document used within the Israeli healthcare system for institutional drug approval. When a patient in a hospital or healthcare facility requires a medication that is not included in the institution's standard formulary, or when a medication requires special authorization, the prescribing physician must complete a 29C form to request approval for the specific drug for that specific patient.

The 29C approval process involves multiple stakeholders. The prescribing physician initiates the request by documenting the clinical justification for the medication, including the diagnosis, previous treatments attempted, and the rationale for the requested drug. The form then moves through an approval chain that may include the department head, the institutional pharmacy committee, and in some cases additional clinical reviewers, depending on the medication and institutional policies.

Traditionally, the 29C process has been paper-based and administratively burdensome, leading to delays in patient treatment and significant documentation overhead. Digitalizing the 29C workflow transforms it into an efficient, trackable process with automated routing, real-time status visibility, electronic approvals, and integrated audit trails that satisfy regulatory requirements.

Formidable Care offers a dedicated digital 29C platform that automates the entire institutional drug approval workflow. The system enables physicians to submit requests electronically, routes forms to the appropriate approvers, provides real-time status tracking, and maintains a complete digital record of all approvals, significantly reducing administrative burden and accelerating patient access to needed medications.